Neuronetics, Inc. (STIM) - רווח נקי למניה (EPS TTM)

Neuronetics, Inc. (STIM) maintains a status as a global savior in non-drug depression therapy, which bolsters its financial stability, where the parameter value equals -0.33. The EPS trend over the last 12 months illustrates the current load. Optimization is driven by the scale of NeuroStar system implementation and the absolute trust of physicians in the efficacy of these neuromodulators, cementing the company's leadership in specialized medical equipment.

For Neuronetics, Inc. (STIM), the rolling year earnings per share reflects the monetization efficiency of its unique magnetic stimulation systems, allowing for an assessment of the actual capital growth per share. This indicator is calculated by dividing the total net income over the last twelve months by the total number of shares, demonstrating the company's ability to convert its pricing power in the non-invasive treatment market into a concrete financial result.